It was reported that higher expression of ERCC1 is associated with favorable prognostic factors for early stage breast cancer patients [18], but with poor outcome for those metastatic TNBC patients treated with platinum-based chemotherapy [19]. The gene discussed is ERCC1; the disease is breast cancer.